A novel theranostic approach that targets RET—a newly identified biomarker for neuroendocrine prostate cancer—enables ...

Compared to conventional imaging techniques, prostate specific membrane antigen (PSMA) PET imaging provides superior ...

KPG-121, a novel cereblon modulator, in patients with metastatic castration resistant prostate cancer: Results of a phase I multiple ascending dose study. Baseline PSMA PET/CT as a predictive ...

Prostate cancer screening is essential for early detection, especially in high-risk groups like men over 50, African Americans, and those with a family history. Routine screening, including PSA tests ...

Findings seen over three months in men with low-grade prostate cancer, hypogonadism treated with radical prostatectomy.